Stock Events

CytomX Therapeutics (CTMX) Q3 2024 Earnings

8AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.19
-0.07
0.05
0.17

Details

Expected EPS
-0.099796
Actual EPS
-0.08
Surprise EPS
0.02
Surprise Percent
+19.84%

Description

CytomX Therapeutics (CTMX) has reported earnings of -0.08 per share for Q3 2024.

0 Comments

Share your thoughts